Invention Grant
- Patent Title: Methods of treating of diabetes and obesity using FGF21 mutants
-
Application No.: US15004281Application Date: 2016-01-22
-
Publication No.: US10011642B2Publication Date: 2018-07-03
- Inventor: Edward John Belouski , Murielle Marie Ellison , Agnes Eva Hamburger , Randy Ira Hecht , Yue-Sheng Li , Mark Leo Michaels , Jeonghoon Sun , Jing Xu
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: AMGEN INC.
- Current Assignee: AMGEN INC.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: A61K38/18
- IPC: A61K38/18 ; C07K14/50 ; C07K16/18 ; A61K39/00 ; A61K38/00
Abstract:
The invention provides methods of treating diabetes, reducing triglyceride levels, and treating obesity by administering to a subject in need there a fusion protein comprising an FGF21 mutant.
Public/Granted literature
- US20160168223A1 FGF MUTANTS AND USES THEREOF Public/Granted day:2016-06-16
Information query
IPC分类:
